McKesson Corporation

MCK Healthcare Medical Distribution

McKesson Corporation’s revenue for fiscal 2026 (year ended March 2026) was $403.4 billion, up 12.4% from fiscal 2025.

Revenue
+7.57%
EPS
+17.0%
Free cash flow
+32.5%
Total debt
+7.08%

Quarter to September 2026, against a year earlier

1,074.06 4.62 +0.43%
Market cap
$125.0B
P/E
27.5×
Fwd P/E
25.4×
Dividend yield
0.32%
F-score
7/9
Altman Z
6.15
Beneish M
−2.34
Dividend safety
86/100

McKesson Corporation (MCK) Price to free cash flow

Alert me on Price to free cash flow

As of 5 November 2026, McKesson Corporation (MCK) trades at a price to free cash flow of 18.2×. Over the past ten years it has ranged from 5.2× (February 2021) to 51.5× (March 2025); the current reading is higher than 90% of that period. That is below the Healthcare sector median of 21.1×.

Price to free cash flow, daily

Embed this chart

Annual newest first

Period Price to free cash flow Change
FY2026 19.8× 20.51%
FY2025 16.4× (16.73%)
FY2024 19.7× 80.44%
FY2023 10.9× (8.69%)
FY2022 12.0× 48.92%
FY2021 8.0× 27.14%
FY2020 6.3× (5.82%)
FY2019 6.7× (13.19%)
FY2018 7.7× (1.42%)
FY2017 7.8× (35.12%)

Quarterly newest first

Period Price to free cash flow Change
Sep 2026 14.5× (0.94%)
Jun 2026 14.6× (26.17%)
Mar 2026 19.8× 88.67%
Dec 2025 10.5× (34.28%)
43 more quarters

Against its own ten years

Low 5.2× High 51.5×
Ten-year median 11.7×
Current reading's percentile 90

Price to free cash flow against peers

What Price to free cash flow is

Price to Free Cash Flow Ratio shows how much investors pay for each dollar of cash a company generates after its capital spending.

Stock Price ÷ ((Operating Cash Flow (TTM) + Property, Plant, Equipment Change (Net) (TTM) + Intangible Assets Change (Net) (TTM)) ÷ (Shares (Basic, Weighted) (latest quarter)))

The full definition of Price to free cash flow →

More on MCK